Daemyung Chemical Reports Amendment to LOGEN Stock Pledge Agreements with Extensions and Additional Collateral; No Ownership Change but High Pledge Ratio Indicates Margin Risk
Daemyung Chemical reported partial amendments to 23 stock pledge agreements for its LOGEN shares while maintaining a 67.75% stake with 38,047,192 shares. The amendments include maturity extensions, additional collateral, and partial repayments, with total pledged shares reaching 29,173,295 or 51.95% of total outstanding shares.
Counterparties include Korea Securities Finance, KB Securities, Hanwha Investment Securities, Cape Investment Securities, IM Securities, BNK Investment Securities, and others, all reputable financial institutions. However, the high pledge ratio of 51.95% poses margin risk if LOGEN's stock price declines. Based on the current price of 1,643 KRW, the pledged shares are valued at approximately 47.9 billion KRW, while total loans amount to about 58.2 billion KRW, indicating a high loan-to-value ratio.
Daemyung Chemical's consolidated financial statements show total assets of 355.3 billion KRW, total liabilities of 245.9 billion KRW, and a debt-to-equity ratio of 225%, reflecting high financial leverage. No shareholder return measures such as treasury stock acquisition or dividend payouts were reported. The amendments do not result in direct equity dilution.
[AI Summary]Daemyung Chemical's amendment of LOGEN stock pledge agreements is a routine adjustment of existing borrowing terms with no change in the majority shareholder's stake and no capital raising for growth purposes. However, the high pledge ratio of 51.95% and loan amounts exceeding collateral value create potential margin call risks upon stock price declines. While counterparties are credible financial institutions, the heavy reliance on secured debt raises concerns about financial soundness.